Clinical Trials
4 trialsNCT06788912 2026-06-01
MK-3475-01E
Merck Sharp & Dohme LLC
Phase 2 Recruiting
NCT06305754 2026-05-29
MK-2870-009
Merck Sharp & Dohme LLC
Phase 3 Active not recruiting
NCT04165096 2026-05-13
MK-3475-01C
Merck Sharp & Dohme LLC
Phase 2 Completed
NCT05834569 2025-09-05
Impact of Maxigesic on Delirium After Minimally Invasive Lung Surgery in Elderly Patients
Korea University Guro Hospital
Phase 4 Terminated